SCHEMBL22180988

SCHEMBL22180988

O=C(CCOCCOCCOCCOCCOCCC(=O)C1CCCCCCCCC1)ON1C(=O)CC(S(=O)(=O)O)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20801357 1.00 — —
SCHEMBL20801353 1.00 — —
SCHEMBL20801421 0.90 — —
SCHEMBL22038805 0.89 — —
SCHEMBL22549366 0.89 — —
SCHEMBL23813737 0.87 CAMK2A (0.32) —
SCHEMBL20801579 0.87 CAMK2A (0.32) —
SCHEMBL20801483 0.86 NAAA (0.34) —
SCHEMBL23813716 0.83 NPC1 (0.35) —
SCHEMBL23813720 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11110178-B2 Antibody adjuvant conjugates THE BOARD OF TRUSTEES OF THE LELAND STANDFORD JUNIOR UNIVERSITY (US) 2021-09-07 — — US disclosed
US-20200206357-A1 ANTIBODY ADJUVANT CONJUGATES BOLT BIOTHERAPEUTICS, INC. 2020-07-02 — — US disclosed
Send feedback